Suppliers and packages for tradename: mydayis
✉ Email this page to a colleague
mydayis
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | MYDAYIS | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 022063 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-468-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-468-01) | 2017-06-20 |
Takeda Pharms Usa | MYDAYIS | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 022063 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-471-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-471-01) | 2017-06-20 |
Takeda Pharms Usa | MYDAYIS | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 022063 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-474-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-474-01) | 2017-06-20 |
Takeda Pharms Usa | MYDAYIS | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 022063 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-477-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-477-01) | 2017-06-20 |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |